U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
173071173071Celebrex vs Tramadol in the Treatment of Chronic Lower Back Pain.CompletedNo Results AvailableBack PainDrug: Tramadol Hydrochloride 50mg|Drug: Celebrex 200mghttps://ClinicalTrials.gov/show/NCT00290901
173072173072Arthroscopic Rotator Cuff Repair of Full Thickness Tears With and Without Arthroscopic AcromioplastyCompletedHas ResultsRotator Cuff Tear|Shoulder Impingement SyndromeProcedure: Acromioplastyhttps://ClinicalTrials.gov/show/NCT00290888
173073173073Implementation of the Canadian C-Spine RuleCompletedNo Results AvailableCspine InjuryBehavioral: Use of Xrays for diagnosishttps://ClinicalTrials.gov/show/NCT00290875
173074173074A Safety and Efficacy Study for Treatment of Painful Vertebral Compression Fractures Caused by OsteoporosisActive, not recruitingNo Results AvailableSpinal FracturesDevice: Percutaneous Vertebral Augmentation of compression fractureshttps://ClinicalTrials.gov/show/NCT00290862
173075173075ImproveR International (BI-001-IM)CompletedNo Results AvailableThrombin-specific Anticoagulant Bivalirudin During Percutaneous Coronary Intervention (PCI)Drug: Bivalirudinhttps://ClinicalTrials.gov/show/NCT00290849
173076173076Assess Efficacy and Safety of TachoComb H vs. Standard Surgical Treatment (i.e. Suturing) in Patients Undergoing Prostatectomy (TC-017-AU)CompletedNo Results AvailableControl of Local Bleeding in Patients Undergoing Prostatectomy.Drug: Human fibrinogen/thrombin and bovine aprotinin (TachoComb H)https://ClinicalTrials.gov/show/NCT00290836
173077173077Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis PatientsRecruitingNo Results AvailableNeurocysticercosisDrug: Albendazole|Drug: Dexamethasone|Drug: Omeprazolehttps://ClinicalTrials.gov/show/NCT00290823
173078173078Bevacizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaCompletedHas ResultsB-cell Chronic Lymphocytic Leukemia|Refractory Chronic Lymphocytic LeukemiaBiological: bevacizumabhttps://ClinicalTrials.gov/show/NCT00290810
173079173079Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM)TerminatedHas ResultsRecurrent Glioblastoma Multiforme (GBM)Drug: Imatinib tablets|Drug: Hydroxyurea capsuleshttps://ClinicalTrials.gov/show/NCT00290771
173080173080Phase IIb Trial of G-2535 (Unconjugated Isoflavones-100) in Women at High Risk for Breast CancerActive, not recruitingNo Results AvailableBreast CancerDietary Supplement: genistein|Other: placebohttps://ClinicalTrials.gov/show/NCT00290758
173081173081Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in SituCompletedNo Results AvailableBreast CancerDrug: letrozole|Drug: tamoxifen citrate|Procedure: conventional surgery|Procedure: neoadjuvant therapyhttps://ClinicalTrials.gov/show/NCT00290745
173082173082Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast CancerCompletedHas ResultsBreast CancerDrug: Intraductal arm|Drug: Intravenous armhttps://ClinicalTrials.gov/show/NCT00290732
173083173083Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By SurgeryTerminatedNo Results AvailableEsophageal CancerDrug: cisplatin|Drug: gefitinib|Drug: irinotecan hydrochloride|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00290719
173084173084A Phase I/II Trial of VELCADE & Gemcitabine for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkin's LymphomaTerminatedNo Results AvailableLymphomaDrug: bortezomib|Drug: gemcitabine hydrochloridehttps://ClinicalTrials.gov/show/NCT00290706
173085173085Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic CancerCompletedHas ResultsPancreatic CancerDrug: Capecitabine|Drug: Docetaxelhttps://ClinicalTrials.gov/show/NCT00290693
173086173086Bortezomib and Celecoxib in Treating Patients With Advanced Solid TumorsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: bortezomib|Drug: celecoxibhttps://ClinicalTrials.gov/show/NCT00290680
173087173087Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell LymphomaRecruitingNo Results AvailableLymphomaBiological: pegfilgrastim|Biological: rituximab|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: prednisone|Drug: vincristine sulfate|Other: pharmacological study|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00290667
173088173088Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in SituTerminatedHas ResultsBreast CancerDrug: Tamoxifen|Procedure: Lumpectomy|Radiation: brachytherapyhttps://ClinicalTrials.gov/show/NCT00290654
173089173089Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic CancerCompletedNo Results AvailableChronic Myeloproliferative Disorders|Leukemia|Lymphoma|Myelodysplastic SyndromesBiological: filgrastim|Biological: graft-versus-tumor induction therapy|Drug: cyclophosphamide|Drug: cyclosporine|Drug: fludarabine phosphate|Drug: mycophenolate mofetil|Procedure: umbilical cord blood transplantation|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00290641
173090173090Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic CancerTerminatedNo Results AvailableChronic Myeloproliferative Disorders|Diamond-blackfan Anemia|Fanconi Anemia|Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative DiseasesDrug: anti-thymocyte globulin|Drug: busulfan|Drug: cyclophosphamide|Drug: cyclosporine|Drug: filgrastim|Drug: melphalan|Drug: methylprednisolone|Drug: mycophenolate mofetil|Procedure: radiation therapy|Procedure: umbilical cord blood transplantationhttps://ClinicalTrials.gov/show/NCT00290628
173091173091Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By SurgeryCompletedHas ResultsColorectal CancerBiological: bevacizumab|Biological: cetuximab|Drug: capecitabine|Drug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00290615
173092173092Early Low Dose Steroid Therapy of Acute Respiratory Distress SyndromeCompletedNo Results AvailableAcute Respiratory Distress Syndrome|Acute Lung Injury|Postoperative ComplicationsDrug: Methylprednisolone sodium succinatehttps://ClinicalTrials.gov/show/NCT00290602
173093173093A Trial of Corticosteroids for Low Back PainCompletedNo Results AvailableRadicular Low Back PainDrug: intramuscular methylprednisolone acetatehttps://ClinicalTrials.gov/show/NCT00290589
173094173094Digestive and Nutritional Effects of Probiotics Supplementation in Premature NewbornsCompletedNo Results AvailableDuration of Parenteral NutritionDietary Supplement: Probiotics supplementation until weight reaches 1800g (Bifidobacterium Longum and Lactobacillus GG )https://ClinicalTrials.gov/show/NCT00290576
173095173095A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase II Study of MK0594 in Patients With Overactive BladderCompletedNo Results AvailableUrinary Incontinence|Overactive BladderDrug: MK0594https://ClinicalTrials.gov/show/NCT00290563
173096173096A Phase IIA Study of MK0457 in Patients With Cancer of the Lung (0457-006)TerminatedNo Results AvailableCarcinoma, Non-Small-Cell LungDrug: MK0457https://ClinicalTrials.gov/show/NCT00290550
173097173097Phase II Study of ZD6474 in Advanced NSCLCTerminatedHas ResultsLung CancerDrug: ZD6474|Drug: Carboplatin|Drug: Paclitaxelhttps://ClinicalTrials.gov/show/NCT00290537
173098173098Early Alimentation Following Colorectal SurgeryRecruitingNo Results AvailableColorectal Neoplasms|Crohn DiseaseBehavioral: Oral alimentation started 12 hours after colorectal surgeryhttps://ClinicalTrials.gov/show/NCT00290524
173099173099Rituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular LymphomaActive, not recruitingNo Results AvailableLymphomaDrug: Fludarabine|Drug: Mitoxantrone|Drug: Rituximab|Drug: Zevalin|Drug: Dexamethasonehttps://ClinicalTrials.gov/show/NCT00290511
173100173100Rituximab-HCVAD in Patients With B-Cell Non-Hodgkin's LymphomaActive, not recruitingNo Results AvailableLymphomaDrug: Rituximab|Drug: Cyclophosphamide|Drug: Doxorubicin|Drug: Vincristine|Drug: Dexamethasone|Drug: Methotrexate|Drug: Cytarabine|Drug: Prednisonehttps://ClinicalTrials.gov/show/NCT00290498

* Görseller ve İçerik tekif hakkına sahip olabilir